Published in J Virol on April 01, 2000
Two cell adhesion molecules, nectin and cadherin, interact through their cytoplasmic domain-associated proteins. J Cell Biol (2000) 1.89
Nectin: an adhesion molecule involved in formation of synapses. J Cell Biol (2002) 1.57
Characterization of human cytomegalovirus glycoprotein-induced cell-cell fusion. J Virol (2005) 1.56
Requirement of interaction of nectin-1alpha/HveC with afadin for efficient cell-cell spread of herpes simplex virus type 1. J Virol (2001) 1.46
Gene transfer by viral vectors into blood vessels in a rat model of retinopathy of prematurity. Br J Ophthalmol (2001) 1.39
The murine homolog of human Nectin1delta serves as a species nonspecific mediator for entry of human and animal alpha herpesviruses in a pathway independent of a detectable binding to gD. Proc Natl Acad Sci U S A (2000) 1.38
A substituted tetrahydro-tetrazolo-pyrimidine is a specific and novel inhibitor of hepatitis B virus surface antigen secretion. Antimicrob Agents Chemother (2007) 1.27
The domains of glycoprotein D required to block apoptosis induced by herpes simplex virus 1 are largely distinct from those involved in cell-cell fusion and binding to nectin1. J Virol (2003) 1.25
Herpes simplex virus with highly reduced gD levels can efficiently enter and spread between human keratinocytes. J Virol (2001) 1.21
Cellular localization of nectin-1 and glycoprotein D during herpes simplex virus infection. J Virol (2003) 1.21
Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry. J Virol (2001) 1.15
alpha-catenin-independent recruitment of ZO-1 to nectin-based cell-cell adhesion sites through afadin. Mol Biol Cell (2001) 1.10
Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesion. Nat Commun (2011) 1.08
Infectious agents and neurodegeneration. Mol Neurobiol (2012) 1.03
Novel, soluble isoform of the herpes simplex virus (HSV) receptor nectin1 (or PRR1-HIgR-HveC) modulates positively and negatively susceptibility to HSV infection. J Virol (2001) 0.99
Substitution in the murine nectin1 receptor of a single conserved amino acid at a position distal from the herpes simplex virus gD binding site confers high-affinity binding to gD. J Virol (2002) 0.98
The herpes simplex virus JMP mutant enters receptor-negative J cells through a novel pathway independent of the known receptors nectin1, HveA, and nectin2. J Virol (2004) 0.97
Phosphoinositide 3 kinase signalling may affect multiple steps during herpes simplex virus type-1 entry. J Gen Virol (2010) 0.94
Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9. J Virol (2007) 0.92
Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread. J Virol (2012) 0.91
Role of nectin in formation of E-cadherin-based adherens junctions in keratinocytes: analysis with the N-cadherin dominant negative mutant. Mol Biol Cell (2003) 0.89
Tin oxide nanowires suppress herpes simplex virus-1 entry and cell-to-cell membrane fusion. PLoS One (2012) 0.89
Role of Nectin-1 and Herpesvirus Entry Mediator as Cellular Receptors for Herpes Simplex Virus 1 on Primary Murine Dermal Fibroblasts. J Virol (2015) 0.86
HIV-associated disruption of tight and adherens junctions of oral epithelial cells facilitates HSV-1 infection and spread. PLoS One (2014) 0.85
Bispecific adapter-mediated retargeting of a receptor-restricted HSV-1 vector to CEA-bearing tumor cells. Mol Ther (2010) 0.83
Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus. J Virol (2016) 0.75
Regulation of the metastasis suppressor Nm23-H1 by tumor viruses. Naunyn Schmiedebergs Arch Pharmacol (2014) 0.75
Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells. J Gen Virol (1968) 26.67
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82
The isolation and properties of a variant of Herpes simplex producing multinucleated giant cells in monolayer cultures in the presence of antibody. Am J Hyg (1959) 9.21
Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell (1996) 9.03
Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science (1998) 7.89
A herpes simplex virus mutant in which glycoprotein D sequences are replaced by beta-galactosidase sequences binds to but is unable to penetrate into cells. J Virol (1988) 7.80
A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell (1999) 6.82
Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J Virol (1992) 5.18
The morphology of herpes virus. Virology (1960) 5.10
A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H. J Virol (1993) 4.67
Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol (1988) 4.32
The properties and sequence of glycoprotein H of herpes simplex virus type 1. Virology (1986) 3.90
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration. J Virol (1987) 3.74
Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J Virol (1987) 3.51
Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol (1999) 3.47
Anti-gD monoclonal antibodies inhibit cell fusion induced by herpes simplex virus type 1. Virology (1983) 3.40
Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J Virol (1994) 3.39
Soluble forms of herpes simplex virus glycoprotein D bind to a limited number of cell surface receptors and inhibit virus entry into cells. J Virol (1990) 3.35
Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry. J Virol (1998) 3.00
Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol (1991) 3.00
Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion. J Virol (1992) 2.93
Specific pseudorabies virus infection of the rat visual system requires both gI and gp63 glycoproteins. J Virol (1993) 2.92
An analysis of the in vitro and in vivo phenotypes of mutants of herpes simplex virus type 1 lacking glycoproteins gG, gE, gI or the putative gJ. J Gen Virol (1994) 2.92
The UL10 gene of herpes simplex virus 1 encodes a novel viral glycoprotein, gM, which is present in the virion and in the plasma membrane of infected cells. J Virol (1993) 2.59
Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol (1995) 2.52
The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene (1995) 2.19
Glycoprotein D of herpes simplex virus encodes a domain which precludes penetration of cells expressing the glycoprotein by superinfecting herpes simplex virus. J Virol (1990) 2.17
The herpes simplex virus gE-gI complex facilitates cell-to-cell spread and binds to components of cell junctions. J Virol (1998) 2.14
Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene (1995) 2.11
Structure-function analysis of soluble forms of herpes simplex virus glycoprotein D. J Virol (1996) 2.05
The first immunoglobulin-like domain of HveC is sufficient to bind herpes simplex virus gD with full affinity, while the third domain is involved in oligomerization of HveC. J Virol (1999) 2.03
Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J Virol (2000) 2.01
The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule. Blood (1998) 1.94
The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci U S A (1998) 1.87
Characterization of pseudorabies virus mutants expressing carboxy-terminal truncations of gE: evidence for envelope incorporation, virulence, and neurotropism domains. J Virol (1997) 1.79
Herpes simplex virus infection and propagation in a mouse L cell mutant lacking heparan sulfate proteoglycans. J Virol (1993) 1.78
Interaction of nectin with afadin is necessary for its clustering at cell-cell contact sites but not for its cis dimerization or trans interaction. J Biol Chem (2000) 1.69
Characterization of the UL10 gene product of herpes simplex virus type 1 and investigation of its role in vivo. J Gen Virol (1993) 1.64
Heparan sulfate glycosaminoglycans as primary cell surface receptors for herpes simplex virus. Adv Exp Med Biol (1992) 1.57
Herpesvirus-induced cell fusion that is dependent on cell surface heparan sulfate or soluble heparin. J Virol (1994) 1.53
Domains of herpes simplex virus I glycoprotein B that function in virus penetration, cell-to-cell spread, and cell fusion. Virology (1992) 1.38
Variability of herpes simplex virus 1 gL and anti-gL antibodies that inhibit cell fusion but not viral infectivity. Virology (1996) 1.35
The UL45 gene product is required for herpes simplex virus type 1 glycoprotein B-induced fusion. J Virol (1994) 1.33
HveA (herpesvirus entry mediator A), a coreceptor for herpes simplex virus entry, also participates in virus-induced cell fusion. J Virol (1998) 1.27
Neurovirulence of pseudorabies virus. Crit Rev Neurobiol (1995) 1.26
Adaptability in herpesviruses: glycoprotein D-independent infectivity of pseudorabies virus. J Virol (1997) 1.24
Anti-idiotypic antibodies mimicking glycoprotein D of herpes simplex virus identify a cellular protein required for virus spread from cell to cell and virus-induced polykaryocytosis. Proc Natl Acad Sci U S A (1996) 1.09
Infection of Chinese hamster ovary cells by pseudorabies virus. J Virol (1999) 0.95
Herpesvirus entry mediator HVEM mediates cell-cell spread in BHK(TK-) cell clones. J Virol (1998) 0.93
Selection of a monoclonal antibody specific for variant B human herpesvirus 6-infected mononuclear cells. J Virol Methods (1995) 0.80
The interaction between N-WASP and the Arp2/3 complex links Cdc42-dependent signals to actin assembly. Cell (1999) 8.07
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A (1980) 6.31
TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell (2001) 4.60
Evidence that herpes simplex virus DNA is transcribed by cellular RNA polymerase B. J Virol (1977) 3.82
The UL20 gene of herpes simplex virus 1 encodes a function necessary for viral egress. J Virol (1991) 3.04
The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol (2000) 2.71
Infectiousness of Mycobacterium tuberculosis in HIV-1-infected patients with tuberculosis: a prospective study. Lancet (2000) 2.67
A two-site monoclonal antibody ELISA for the quantification of the major Dermatophagoides spp. allergens, Der p I and Der f I. J Immunol Methods (1989) 2.56
Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol (2007) 2.51
Numbers of Giardia in the feces of infected children. Am J Trop Med Hyg (1975) 2.38
Glycoprotein D or J delivered in trans blocks apoptosis in SK-N-SH cells induced by a herpes simplex virus 1 mutant lacking intact genes expressing both glycoproteins. J Virol (2000) 2.26
The human PRR2 gene, related to the human poliovirus receptor gene (PVR), is the true homolog of the murine MPH gene. Gene (1995) 2.19
Cdc42 is required for PIP(2)-induced actin polymerization and early development but not for cell viability. Curr Biol (2000) 2.19
Complementary DNA characterization and chromosomal localization of a human gene related to the poliovirus receptor-encoding gene. Gene (1995) 2.11
Herpes simplex virus envelopment and maturation studied by fracture label. J Virol (1992) 2.10
Nectin4/PRR4, a new afadin-associated member of the nectin family that trans-interacts with nectin1/PRR1 through V domain interaction. J Biol Chem (2001) 2.09
Studies of electroimmunodiffusion: immunochemical quantitation of proteins in dilute solutions. Immunochemistry (1969) 2.05
Masitinib is safe and effective for the treatment of canine mast cell tumors. J Vet Intern Med (2008) 2.05
Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia. Br J Haematol (1990) 2.02
Nectin2alpha (PRR2alpha or HveB) and nectin2delta are low-efficiency mediators for entry of herpes simplex virus mutants carrying the Leu25Pro substitution in glycoprotein D. J Virol (2000) 2.01
Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine (1992) 1.97
The human poliovirus receptor related 2 protein is a new hematopoietic/endothelial homophilic adhesion molecule. Blood (1998) 1.94
The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.91
Construction and properties of a cell line constitutively expressing the herpes simplex virus glycoprotein B dependent on functional alpha 4 protein synthesis. J Virol (1986) 1.89
The V domain of herpesvirus Ig-like receptor (HIgR) contains a major functional region in herpes simplex virus-1 entry into cells and interacts physically with the viral glycoprotein D. Proc Natl Acad Sci U S A (1998) 1.87
Redistribution of microtubules and Golgi apparatus in herpes simplex virus-infected cells and their role in viral exocytosis. J Virol (1995) 1.86
Cognitive and psychosocial features of childhood and juvenile MS. Neurology (2008) 1.85
Microsatellite marker polymorphism and mapping in pea (Pisum sativum L.). Theor Appl Genet (2005) 1.79
Electrocautery as a factor in seroma formation following mastectomy. Am J Surg (1998) 1.75
Physiological outcomes of aerobic exercise training in hemiparetic stroke patients. Stroke (1995) 1.73
Thoracoscopic repair of H-type tracheoesophageal fistula in the newborn: a technical case report. J Pediatr Surg (2004) 1.72
Clinical phenotype associated with terminal 2q37 deletion. Clin Genet (1995) 1.63
1alpha,25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem (2001) 1.62
Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J (1993) 1.59
Infectivity and glycoprotein processing of herpes simplex virus type 1 grown in a ricin-resistant cell line deficient in N-acetylglucosaminyl transferase I. J Virol (1982) 1.57
Studies on benzhydrazone, a specific inhibitor of herpesvirus glycoprotein synthesis. Size distribution of glycopeptides and endo-beta-N-acetylglucosaminidase-H treatment. Arch Virol (1981) 1.55
Mononuclear cell chemoattractant activity from cultured arterial smooth muscle cells. Exp Mol Pathol (1982) 1.51
Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI) Eur Heart J (1997) 1.47
Mapping of herpes simplex virus 1 genes with mutations which overcome host restrictions to infection. Proc Natl Acad Sci U S A (1994) 1.46
Localization and putative function of the UL20 membrane protein in cells infected with herpes simplex virus 1. J Virol (1994) 1.45
In vitro generation of dendritic cells from human blood monocytes in experimental conditions compatible for in vivo cell therapy. J Hematother Stem Cell Res (2000) 1.43
Influence of high-grade prostatic intra-epithelial neoplasia on total and percentage free serum prostatic specific antigen. BJU Int (1999) 1.42
Conservative surgery and radiotherapy in early stage breast cancer: a comparison between tumourectomy and quadrantectomy. Radiother Oncol (1998) 1.42
Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol (1999) 1.39
Combined suicide and cytokine gene therapy for peritoneal carcinomatosis. Gut (2000) 1.39
The murine homolog of human Nectin1delta serves as a species nonspecific mediator for entry of human and animal alpha herpesviruses in a pathway independent of a detectable binding to gD. Proc Natl Acad Sci U S A (2000) 1.38
Prevalence of dust mites in the homes of people with asthma living in eight different geographic areas of the United States. J Allergy Clin Immunol (1992) 1.34
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia. Leukemia (2009) 1.33
Development of a rapid and sensitive test for identification of major pathogens in bovine mastitis by PCR. J Clin Microbiol (2001) 1.33
Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation. EMBO J (1999) 1.33
Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis (1999) 1.33
Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J Clin Microbiol (1996) 1.32
The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene (1993) 1.32
Maize introduction into Europe: the history reviewed in the light of molecular data. Theor Appl Genet (2002) 1.30
The mouse W/c-kit locus. Ciba Found Symp (1990) 1.30
Processing of herpes simplex virus-1 glycans in cells defective in glycosyl transferases of the Golgi system: relationship to cell fusion and virion egress. Virology (1983) 1.30
Two distinct TL-like molecular subsets defined by monoclonal antibodies on the surface of human thymocytes with different expression on leukemia lines. Immunogenetics (1984) 1.30
Engraftment of allogeneic mesenchymal stem cells in the bone marrow of a patient with severe idiopathic aplastic anemia improves stroma. Leukemia (2003) 1.29
Comparison of Candida-delayed hypersensitivity skin test size with lymphocyte transformation, migration inhibitory factor production and antibody titer. Int Arch Allergy Appl Immunol (1974) 1.29
Regulation of glycoprotein D synthesis: does alpha 4, the major regulatory protein of herpes simplex virus 1, regulate late genes both positively and negatively? J Virol (1988) 1.26
Anti-CD2 (sheep red blood cell receptor) monoclonal antibodies and T cell activation. I. Pairs of anti-T11.1 and T11.2 (CD2 subgroups) are strongly mitogenic for T cells in presence of 12-O-tetradecanoylphorbol 13-acetate. Eur J Immunol (1986) 1.25
The murine W/c-kit and Steel loci and the control of hematopoiesis. Semin Hematol (1991) 1.25
Human herpesvirus-6 glycoprotein H and L homologs are components of the gp100 complex and the gH external domain is the target for neutralizing monoclonal antibodies. Virology (1993) 1.24
Intermediate forms of glycoconjugates are present in the envelope of herpes simplex virions during their transport along the exocytic pathway. Virology (1995) 1.24
Human nectin3/PRR3: a novel member of the PVR/PRR/nectin family that interacts with afadin. Gene (2000) 1.24
Expression and regulation of glycoprotein C gene of herpes simplex virus 1 resident in a clonal L-cell line. J Virol (1986) 1.18
Chimeric nectin1-poliovirus receptor molecules identify a nectin1 region functional in herpes simplex virus entry. J Virol (2001) 1.15
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene (2006) 1.15
Infusion of allogeneic-related HLA mismatched mesenchymal stem cells for the treatment of incomplete engraftment following autologous haematopoietic stem cell transplantation. Leukemia (2007) 1.13
Paediatric mastocytosis: a systematic review of 1747 cases. Br J Dermatol (2015) 1.13
Sialylated oligosaccharides O-glycosidically linked to glycoprotein C from herpes simplex virus type 1. J Virol (1985) 1.13
Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations. Cancer (1986) 1.12
Level of Flt3-ligand in plasma: a possible new bio-indicator for radiation-induced aplasia. Int J Radiat Biol (2001) 1.11
Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthritis Cartilage (2002) 1.11
Synthesis and biological activity of partially modified retro-inverso pseudopeptide derivatives of the C-terminal tetrapeptide of gastrin. J Med Chem (1987) 1.11
Effect of ribosome-inactivating proteins on virus-infected cells. Inhibition of virus multiplication and of protein synthesis. Arch Virol (1982) 1.10
Comparative study on O-linked oligosaccharides of glycoprotein D of herpes simplex virus types 1 and 2. J Gen Virol (1988) 1.10
Anti-idiotypic antibodies mimicking glycoprotein D of herpes simplex virus identify a cellular protein required for virus spread from cell to cell and virus-induced polykaryocytosis. Proc Natl Acad Sci U S A (1996) 1.09
[A comparative study of the feasibility and limits of ambulatory surgery in infants under and over one year of age]. Ann Chir (2004) 1.08
Hepatitis B virus (HBV) binding factor in human serum: candidate for a soluble form of hepatocyte HBV receptor. J Virol (1993) 1.08